| 注册
首页|期刊导航|肿瘤药学|苦参注射液联合吉西他滨+顺铂化疗方案治疗晚期膀胱癌的近期疗效及对生存时间的影响

苦参注射液联合吉西他滨+顺铂化疗方案治疗晚期膀胱癌的近期疗效及对生存时间的影响

HAN Zhixing ZHAO Yuqian LIU Qingjun JI Shiqi CHENG Wenlong ZHANG Haijian XUE Peng

肿瘤药学2019,Vol.9Issue(1):112-116,5.
肿瘤药学2019,Vol.9Issue(1):112-116,5.DOI:10.3969/j.issn.2095-1264.2019.01.24

苦参注射液联合吉西他滨+顺铂化疗方案治疗晚期膀胱癌的近期疗效及对生存时间的影响

Short-term Effects of Matrine Injection Combined with Gemcitabine + Cisplatin Chemotherapy on Advanced Bladder Cancer Patients and on the Survival Time★

HAN Zhixing 1ZHAO Yuqian 1LIU Qingjun 1JI Shiqi 1CHENG Wenlong 1ZHANG Haijian 1XUE Peng2

作者信息

  • 1. Department of Urology, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China
  • 2. Department of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China
  • 折叠

摘要

Abstract

Objective To evaluate the short-term efficacy of matrine injection combined with gemcitabine + cisplatin chemotherapy for advanced bladder cancer patients and the effect on survival time. Methods The clinical data of eighty-one cases of advanced bladder cancer patients in our hospital between March 2014 and May 2016 were retrospectively analyzed. According to the treatment methods, pa-tients were divided into control group (n=42, treated with gemcitabine + cisplatin chemotherapy) and observation group (n=39, treated with matrine injection combined with gemcitabine + cisplatin chemotherapy). All had treatment for six courses. The overall efficacy, immunocyte distribution and drug toxicity were compared between two groups after 6 courses of treatment. All were followed up for two years and the survival time was recorded. Results The respone rate (RR) and disease control rate (DCR) of the observation group were higher than those of the control group (P<0.05). The percentage of Treg cells in peripheral blood of the observation group was lower than that of control group, but the proportion of CTL and NK cells of the observation group were higher than that of control group (P<0.05). During the treatment, there were no significant differences in incidences of adverse drug reactions between two groups (P>0.05). During follow-up period, the 1-year survival rate and 2-year survival rate of the observation group were higher than those of the control group, and the progression-free survival time and total survival time of the observation group were also longer than those of the control group (P<0.05). Conclusion Adjuvant therapy with matrine injection on the basis of gemcitabine + cisplatin can further improve the short-term efficacy and optimize immune function for pateints with advanced bladder cancer. It could also prolong survival time of pateints.

关键词

晚期膀胱癌/苦参注射液/免疫功能/生存时间

Key words

Advanced bladder cancer/ Matrine injection/ Immunologic function/ Survival time

分类

医药卫生

引用本文复制引用

HAN Zhixing,ZHAO Yuqian,LIU Qingjun,JI Shiqi,CHENG Wenlong,ZHANG Haijian,XUE Peng..苦参注射液联合吉西他滨+顺铂化疗方案治疗晚期膀胱癌的近期疗效及对生存时间的影响[J].肿瘤药学,2019,9(1):112-116,5.

基金项目

基金项目:北京市卫生发展科研专项资助项目(2016-75). (2016-75)

肿瘤药学

OACSTPCD

2095-1264

访问量0
|
下载量0
段落导航相关论文